Latest Share Chat

ValiRx Share News (VAL)

ValiRx Information

Buy VAL Shares
Add VAL to Watchlist
Add VAL to Alert

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 3.25

Bid: 3.20

Ask: 3.30

Change: 0.00 (0.00%)

Spread: 0.10 (3.125%)

Open: 3.25

High: 3.25

Low: 3.25

Prev. Close: 3.25

Last checked at -

ValiRx Raises GBP1M Through Placing; Shares Fall Toward Placing Price

Fri, 15th Nov 2013 10:28

LONDON (Alliance News) - Pharmaceutical company ValiRx PLC Friday said that it has raised GBP1 million in a placing of 307.7 million shares with institutional and other investors.

The cancer drug developer said that it will use the funds to further advance its development programmes.

The shares were priced at 0.325 pence per share. Following the placing, ValiRx has 2.0 million shares issued.

ValiRx shares were amongst the biggest decliners Friday morning, down 18% at 0.352 pence per share.

By Rowena Harris-Doughty; rowenaharrisdoughty@alliancenews.com; @rharrisdoughty

More News

10 Feb 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

14 Jan 2020 14:50

ValiRx signs letter of intent in a bid to fund VAL401

(Sharecast News) - Clinical-stage biotechnology company ValiRx updated the market on its subsidiary joint venture, ValiSeek, and its cancer therapeutic, VAL401 on Tuesday.

14 Jan 2020 11:08

ValiRx Joint Venture Partner Enters Agreement For VAL401 Funding

6 Jan 2020 09:59

ValiRx Raises GBP200,000 To Progress Product Development

16 Dec 2019 10:17

ValiRx Reveals "Clear Impact" Of VAL201 On Prostate Cancer Patients

28 Nov 2019 16:13

ValiRx granted US patent for 'VAL201' compound

(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Thursday that the US Patent and Trademark Office has granted patent number 10,400,008, titled 'Modulators Of The SRC-Kinase Activity For Preventing Or Treating Metastatic Cancer', to its lead therapeutic compound 'VAL201'.

28 Nov 2019 15:57

ValiRx Granted "Key" US Patent Protection For VAL201 Cancer Treatment

14 Oct 2019 13:44

ValiRx Raises GBP350,000 Through Placing To Progress Clinical Trials

26 Sep 2019 11:43

ValiRx Reports Narrowed Loss In First Half As Expenses Reduce

24 Sep 2019 12:40

ValiRx Receives GBP423,000 Research & Development Credit From UK HMRC

10 Sep 2019 13:45

ValiRx Prostate Cancer Drug VAL201 Still Meeting Endpoints

(Alliance News) - ValiRx PLC on Tuesday said its VAL201 lead compound is still meeting all of its published endpoints and is behaving as expected in prostate cancer.VAL201 has been as a and

1 Aug 2019 12:01

ValiRx Granted European Patent Allowance For VAL301 Compound

(Alliance News) - Clinical stage biotechnology firm ValiRx PLC said Thursday it has been granted a patent notice of allowance for its pre-clinical therapeutic compound, VAL301, from the European a

23 Jul 2019 16:25

Monecor Takes Nearly 6% Holding In Biotechnology Firm ValiRx

(Alliance News) - ValiRx PLC on Tuesday said Monecor London Ltd now holds 5.7% interest in the biotechnology company.Prior to this transaction on Monday, Monecor's holding totalled were

26 Jun 2019 14:30

US Grands Patent Claim For valiRx's VAL201 In Metastatic Cancer

(Alliance News) - ValiRx PLC on Wednesday said the US has allowed a patent claim for the use of VAL201 in metastatic cancer.Shares in ValiRx were down 7.1% at 0.21 pence in afternoon trade

26 Jun 2019 10:53

ValiRx gets US patent protection for use of VAL201 peptide

(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Wednesday that the US Patent and Trademark Office (USPTO) has allowed patent claims directed towards a method of preventing the worsening of symptoms of metastatic cancer, reducing the progression of metastatic cancer, or treating metastatic cancer - including prostate cancer - by administration of the 'VAL201' peptide.

Latest Share Chat

ValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ValiRx Raises GBP1M Through Placing; Shares Fall Toward Placing Price

Login to your account

Quickpicks are a member only feature

Login to your account